Company / Return on Assets (ROA)
INOVIO PHARMACEUTICALS, INC. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-144.3%
FY2025
5-year range
-177.6% / -24.1%
FY2021-FY2025
Trend
-20.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -177.6% in FY2023 to -15.6% in FY2017.
Based on SEC 10-K filings.
-144.3% in FY2025 with a 5-year CAGR of -126.4%.
Improved from -177.6% to -144.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -96.6pp
- 5-Year Change
- -126.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 20.9% year-over-year.
- Peak return on assets (roa) was recorded in FY2017.
- Lowest return on assets (roa) in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -144.3% | -20.9% |
| FY2024 | -119.4% | +32.8% |
| FY2023 | -177.6% | -272.0% |
| FY2022 | -47.8% | -98.4% |
| FY2021 | -24.1% | -34.0% |
| FY2020 | -18.0% | +70.7% |
| FY2019 | -61.3% | -8.9% |
| FY2018 | -56.2% | -260.7% |
| FY2017 | -15.6% | +25.0% |
| FY2016 | -20.8% | +32.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026